Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Med Sci Monit ; 18(9): CR564-8, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22936192

RESUMO

BACKGROUND: Recent guidelines recommend inhaled corticosteroids as the first-line treatment for persistent asthma. However, long-term corticosteroid treatment in children has raised concerns about potential growth rate deceleration. We aimed to assess the association of growth velocity with the use of inhaled corticosteroids in prepubertal children with asthma in a "real-life" setting. MATERIAL/METHODS: This study included 844 children aged 4-9.5 years coming to the hospital for regular check-ups between October 2006 and February 2009 for asthma with/without allergic rhinitis and no other known constraints of growth. Out of the 844 children, 790 had all data needed for analysis--245 children were not treated with ICS, 545 children received ICS (fluticasone, budesonide) with/without INCS (fluticasone, mometasone or budesonide). During the study period, 48 children with/without ICS received short SCS courses. RESULTS: Mean (SE) height at the first check-up was 123.1 (0.31) cm; range (100.0-147.8 cm). Mean (SE) linear growth velocity (LGV) of the included children was 0.185 (0.0035) mm/day between 2 check-ups. No significant difference was found in LGV between the group not treated with ICS (0.180 mm/day±0.0055) and the group treated with ICS (0.187±0.0044 mm/day). Also, there was no statistical difference between subgroups according to additional therapy with INCS and SCS. No significant correlation was found for LGV and daily dose of ICS (r=0.086, p>0.05). CONCLUSIONS: In our retrospective study using electronic hospital database, ICS and combined use of corticosteroids did not show any association with LGV in prepubertal asthmatic children in a "real-life" setting.


Assuntos
Corticosteroides/farmacologia , Antiasmáticos/farmacologia , Asma/tratamento farmacológico , Crescimento/efeitos dos fármacos , Administração por Inalação , Administração Intranasal , Corticosteroides/administração & dosagem , Análise de Variância , Antiasmáticos/administração & dosagem , Estatura/efeitos dos fármacos , Criança , Pré-Escolar , Humanos , Estudos Retrospectivos
2.
Int J Environ Health Res ; 22(4): 355-61, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22149107

RESUMO

Passive smoking has been found to be associated with a large number of disorders of passive smokers. It seems that the children are the most susceptible population for harmful effects of passive smoke exposure. The aim of this study was to evaluate the effect of passive smoking on children's functional abilities. The target population was 199 children who were 13-15 years old at the time of the study. For the assessment of motor skills 6-min run test was used. Children exposed to passive smoking by their mothers had statistically significant lower functional abilities (r =-0.7029; 95% CI -0.7707 to -0.6194; p < 0.0001). We also found statistically significant difference if the both parents are smokers (r =-0.3343; 95% CI -0.4595 to -0.1961; p < 0.0001). The results of our study did not show statistically significant difference if the children are exposed to cigarette smoke by their fathers (r = 0.03139; 95% CI -0.1171 to 0.1785; p = 0.6792). Public health preventive actions should go toward minimizing the exposure of children to passive smoking by counseling the smoking parents that quitting smoking provides enormous health benefits not only to them but also to their children.


Assuntos
Exposição Ambiental , Destreza Motora/efeitos dos fármacos , Poluição por Fumaça de Tabaco/efeitos adversos , Adolescente , Croácia , Feminino , Humanos , Masculino , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...